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Abstract
Aquaporin 3 (AQP3) is an aquaglyceroporin which transports water, glycerol and small solutes across the plasma
membrane. Its functions are not limited to fluid transport but also involve the regulation of cell proliferation, migration,
skin hydration, wound healing and tumorigenesis. While AQP3 has been reported to play an important role in
keratinocyte proliferation, its role in differentiation remains controversial. Our study demonstrated that the expression
of AQP3 was regulated during differentiation and that it participated in keratinocyte differentiation control. We further
revealed that AQP3 was a transcriptional target of Notch signaling, a critical pathway regulating keratinocyte
differentiation and tumor suppression, and it regulated differentiation through a reciprocal negative feedback loop
with Notch1. When the expression level of AQP3 was elevated, impaired barrier integrity and increased pro-
inflammatory cytokine production ensued, mimicking the pathological conditions in Notch deficient mice and in atopic
dermatitis. Dysregulation of AQP3 and Notch receptors has been reported in several skin diseases, including skin
cancer. Our discovery of the novel AQP3-Notch1 axis may provide insight into epidermal homeostasis control and
possible translational applications, including its potential use as a biomarker for molecular diagnosis in environmental
studies.
Citation: Guo L, Chen H, Li Y, Zhou Q, Sui Y (2013) An Aquaporin 3-Notch1 Axis in Keratinocyte Differentiation and Inflammation. PLoS ONE 8(11):
e80179. doi:10.1371/journal.pone.0080179
Editor: Andrzej T Slominski, University of Tennessee, United States of America
Received August 6, 2013; Accepted October 4, 2013; Published November 8, 2013
Copyright: © 2013 Guo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from China Ministry of Science and Technology (2011CB503802 to QXZ), National Natural Science
Foundation of China as a key project (grant No. 21037002 to QXZ) and National Natural Science Foundation of China Grants (grant No. 81171495 and
81271765 to HXC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
* E-mail: suiyang@iss.whu.edu.cn (YS); zhouqx@nankai.edu.cn (QXZ)
Introduction
The aquaporins are a family of transmembrane channels
transporting water and in some cases, small solutes across the
plasma membrane driven by osmotic gradients [1]. Currently,
13 mammalian aquaporins have been identified (AQP0-
AQP12). They are expressed in tissues involved in active fluid
transport such as kidney tubules, secretory epithelia and
microvascular endothelia as well as tissues without significant
fluid transport, including the epidermis, skeletal muscle,
adipose tissue, erythrocytes and leukocytes [1]. Studies from
aquaporin-null mice revealed important functions of aquaporins
in urine concentration [2,3], brain water balance [4,5] and
neuroexcitation [6–8], corneal transparency and retina swelling
[9,10], skin hydration and elasticity [11,12], cell migration
[13–16], cell proliferation [14,17], wound healing [15],
angiogenesis [13] and fat metabolism [18].
Aquaporin-3 (AQP3) is the predominant and most widely
studied aquaporin in mammalian skin. It is an aquaglyceroporin
and is capable of transporting water, glycerol, urea and
hydrogen peroxide [1]. The functions of AQP3 in skin are
mostly concluded from studies in AQP3-deficient mice. AQP3-
mediated glycerol transport plays an important role in stratum
corneum hydration, skin elasticity, barrier recovery, wound
healing and cell proliferation whereas AQP3-mediated water
transport is critical for cell migration [11,15]. Recently, AQP3
was reported to mediate hydrogen peroxide uptake which was
responsible for regulation of T-cell migration and cutaneous
immune response [19,20]. The above functions of AQP3 may
explain, in part, the resistance of AQP3-deficient mice to
epidermal tumor formation in chemical carcinogen-induced
tumorigenesis [21]. The homeostasis of mammalian skin,
especially the epidermis, is maintained by tightly regulated
proliferation/differentiation. Despite its known function in
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keratinocyte proliferation, the role of AQP3 in keratinocyte
differentiation remains controversial.
Notch signaling is an evolutionarily conserved cell-cell
communication pathway and plays a critical role in various
physiological and pathological processes [22]. There are four
vertebrate Notch receptors, Notch1-4. The Notch proteins are
type-1 trans-membrane receptors, upon interaction with
membrane-bound ligands, such as delta-like, or Jagged on
neighboring cells, the receptors will undergo two proteolytic
cleavages to become activated. The first cleavage is mediated
by metalloproteases, ADAM10/TACE/Kuz/SUP-17, in the
extracellular portion of the Notch C-terminus. This cleavage
produces the membrane–anchored Notch extracellular
truncation (NEXT) which is subsequently cleaved by
intramembrane aspartyl protease complex γ-secretase, leading
to the release of Notch intracellular domain (NICD) from the
plasma membrane. The NICD will then translocate to the
nucleus, displace corepressor complexes associated with
DNA-binding protein CSL and form a transcriptional complex
with CSL and coactivators to activate the transcription of Notch
target genes [23]. The best characterized Notch signaling
targets are members of the HES and HERP families of bHLH
transcriptional repressors [24]. In mammalian skin, Notch1-
mediated signaling exerts a critical pro-differentiation and
tumor suppressing function [25–27].
Using gain and loss of function approaches, we
demonstrated that AQP3 regulated differentiation through a
reciprocal negative feedback loop with Notch signaling. Its
increased expression, as observed in atopic dermatitis, led to
decreased expression of an important epidermal barrier
component, filaggrin, and increased expression of pro-
inflammatory cytokines, including TNFα and CCL5. The
interconnection between AQP3 and Notch1 may have general
relevance in the physiological and pathological processes of
the skin.
Results
1): The expression of AQP3 decreases during late
differentiation in human keratinocytes concurrent with
Notch signaling activation
To determine the potential involvement of AQP3 in
keratinocyte differentiation, we first examined whether the
expression of AQP3 was regulated during differentiation.
Consistent with previous studies, immunofluorescence staining
of intact human skin showed that AQP3 was mostly expressed
on the plasma membrane of keratinocytes in both basal and
spinous layers of the epidermis with decreased expression
towards the stratum corneum [28,29] (Figure 1A). In parallel,
the expression of AQP3 was evaluated in cultured primary
human keratinocytes (HKCs) under proliferating condition or
upon induction of differentiation by high cell density [30,31].
The expression of markers characteristic of basal (integrin β4),
spinous (keratin 1 and involucrin) and granular (loricrin and
filaggrin) layers, proliferation marker (Ki67) and cell cycle
inhibitor p21WAF1/Cip1 (CDKN1A) was assessed to verify
proliferation and differentiation progression. The results
showed that high cell density led to a decrease in the
expression of Ki67 and integrin β4 and an increase in CDKN1A
and all of the differentiation markers (keratin 1, involucrin,
loricrin and filaggrin), reflecting differentiation induction and
accompanying cell cycle exit (Figure 1B, C). Quantitative real-
time PCR and immunoblot analysis showed that AQP3 was
expressed at all cell densities: pre-confluent (70% confluent),
confluent (100% confluent) and post-confluent (1-7 days after
reaching confluence), with slight increase in early post-
confluent time points (1D and 3D) and sharp decrease in late
time points (5D and 7D) (Figure 1B, C). AQP3 expression
increased during early differentiation when keratin 1 started to
appear and decreased during late differentiation when loricrin
began to be expressed (Figure 1B, C). Interestingly, the
decrease in AQP3 expression at post-confluent day 5 and 7
coincided with an increased expression of activated
Notch1(N1ICD) (Figure 1C). Given the known role of Notch
signaling in keratinocyte differentiation [25,26,32], the inverse
expression pattern of N1ICD and AQP3 suggested that AQP3
might be negatively regulated during differentiation by Notch
signaling.
2): AQP3 is under the negative regulation of Notch
signaling
To assess whether AQP3 was under Notch signaling control,
we evaluated its expression in HKCs upon either Notch
signaling inactivation by CSL knockdown or γ-secretase
inhibition, or activation of the pathway by overexpression of
activated Notch1. In differentiating HKCs where Notch
signaling is activated, Notch signaling inactivation by CSL
knockdown led to a reduced expression of Notch canonical
target HES1 and differentiation markers. However, the
expression of AQP3 increased at both mRNA and protein
levels (Figure 2A). Similar induction of AQP3 was observed in
differentiating HKCs treated with DAPT, a γ-secretase inhibitor
which suppresses endogenous Notch activation (Figure 2B)
[33]. In contrast, constitutive expression of activated Notch1 in
proliferating HKCs by retroviral infection resulted in a reduction
of AQP3 expression, whereas HEY1, another canonical target
of Notch signaling was greatly induced (Figure 2C). To
substantiate our findings, bioinformatic analysis was performed
to search for putative CSL binding sites located within potential
transcription regulatory regions of the AQP3 gene utilizing
chromatin configuration information provided by the ENCODE
project (http://genome.ucsc.edu/ENCODE/). The motif search
identified a consensus CSL binding site located about 750bp
downstream of transcription start site (TSS) of the AQP3 gene
in a region enriched for active promoter marks, including
H3K4me3, H3K9ac and H3K27ac and with DNase I
hypersensitivity. Chromatin immunoprecipitation (ChIP) assay
was performed with extract from HKCs under high cell density
differentiating condition using CSL antibody. In differentiating
HKCs, endogenous CSL bound to its consensus binding site
located in the AQP3 gene promoter in parallel to its binding to
the promoters of HES1 and HES4 genes, two canonical targets
of Notch signaling, whereas no binding was detected in α
satellite repeat element located in the pericentromeric regions
of chromosomes, indicating that AQP3, like HES1 and HES4
AQP3 in Epidermal Differentiation and Inflammation
PLOS ONE | www.plosone.org 2 November 2013 | Volume 8 | Issue 11 | e80179
Figure 1.  AQP3 expression is down-regulated during late differentiation concurrent with Notch signaling activation.  (A)
Immunofluorescence analysis of AQP3 expression in normal human skin. Frozen sections (8 μm) of normal human skin were
stained with an antibody against RORα (green) and Hoechst (blue) for DNA. Images are representatives of several independent
fields. Bar=100 μm. (B) qRT-PCR analysis of expression of the indicated genes in HKCs under proliferating condition (70%
confluence, cf) and at various time (days, D) of differentiation induced by high cell density. Values are normalized to reference
ribosomal gene RPLP0, and presented as fold-changes relative to cells under proliferating condition ± S.E.M. n=3. ** p< 0.01, *** p
< 0.001, **** p<0.0001. (C) Immunoblot analysis of indicated proteins in the same time course experiment as in (B).
doi: 10.1371/journal.pone.0080179.g001
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was under direct transcriptional control of Notch signaling
(Figure 2D).
3): AQP3 inhibits keratinocyte differentiation through
down-modulating Notch1 expression
The negative regulation of AQP3 by Notch signaling
suggested that down-modulation of AQP3 might be required for
normal differentiation. To evaluate the functional significance of
AQP3 expression, we used gain and loss of function
approaches to manipulate AQP3 level in HKCs. In loss of
function approach, two individual validated siRNA for AQP3
were used to silence AQP3 expression in HKCs under
proliferating condition (Figure 3A). In agreement with previous
reports[21], attenuated AQP3 expression caused growth
inhibition (Figure 3B). However, the expression of cell cycle
regulators, including p21WAF1/Cip1, and p16Ink4A or apoptosis
regulator p53 was not affected by AQP3 silencing, suggesting
the growth inhibition observed was likely due to other
mechanisms (Figure 3C). In contrast to previous reports [29],
AQP3 silencing led to an increased expression of early
markers such as keratin 10 and involucrin at both mRNA and
protein levels as well as an increase in filaggrin mRNA, a gene
normally being transcribed during late differentiation (Figure
3D). Of note, the level of activated Notch1 was significantly
increased upon AQP3 silencing, pointing to the possibility that
AQP3 silencing-induced differentiation could be the
consequence of activated Notch signaling (Figure 3D). To test
this hypothesis, HKCs transfected with AQP3 siRNAs were
cultured in the presence or absence of DAPT and the
expression of differentiation markers was evaluated. In the
presence of DAPT, the induction of keratin 1 and involucrin
was mostly abrogated, confirming that their induction by AQP3
was through Notch activation (Figure 3E). Filaggrin has been
reported to be under the negative regulation of Notch signaling
[26], AQP3 silencing caused a significant induction of filaggrin
expression in HKC which was slightly augmented by DAPT
treatment, suggesting the induction of filaggrin by AQP3 was
independent of Notch signaling (Figure 3E).
In the converse experiments, overexpressing AQP3 in
differentiating keratinocytes led to a reduced expression of
involucrin, keratin 10, filaggrin as well as Notch1 (Figure 4A). In
summary, the gain and loss of function studies demonstrated
that AQP3 negatively regulated differentiation possibly through
its interconnection with Notch signaling.
4): Increased AQP3 expression results in impaired
epidermal barrier and pro-inflammatory cytokine
production
Increased expression of AQP3 has been reported in atopic
dermatitis, one of the most common inflammatory skin
diseases [34,35]. An independent line of studies has found that
Notch deficient epidermis exhibited atopic dermatitis-like
phenotype [36,37]. To determine whether AQP3 played a role
in the inflammatory response, we surveyed the expression of a
number of pro-inflammatory cytokines upon AQP3 silencing or
overexpression in comparison to Notch signaling inhibition by
DAPT treatment in HKCs. The results showed that among the
factors tested, TNFα and CCL5 were consistently modulated in
these various conditions: AQP3 silencing down-regulated
whereas AQP3 overexpression and Notch signaling inhibition
up-regulated their expression (Figure 4B). Together with its
capability of suppressing filaggrin expression, one of the
important proteins in epidermal barrier, and differentiation
markers, AQP3 overexpression led to barrier defect and pro-
inflammatory cytokines production.
Discussion
Epidermal homeostasis is maintained by a fine balance
between proliferation and differentiation. AQP3-mediated water
and glycerol transport play an important role in a number of
cellular and physiological processes in the epidermis, such as
cell migration, proliferation, hydration, wound healing and
tumorigenesis [38]. Our investigation of AQP3’s involvement in
keratinocyte differentiation and its interconnection with Notch
signaling was ignited by the conflicting results in the literature
as well as the inverse expression patterns of Notch receptors
and AQP3 in skin diseases [29,36,39,40]. We showed that
AQP3 was expressed not only in proliferating keratinocytes but
also cells undergoing early differentiation. We further
demonstrated that the down-modulation of AQP3 during late
differentiation was concurrent with Notch activation and that
AQP3 was under the negative regulation of Notch. In
proliferating and early differentiating keratinocytes, AQP3
suppressed differentiation and promoted proliferation through
down-regulation of Notch1. Our study supports the notion that
AQP3 regulates keratinocyte differentiation and identified
Notch signaling as the mediator of this function.
Previously, Hara-Chikuma et. al. reported that AQP3 was not
involved in keratinocyte differentiation using AQP3 null mice
and neonatal human keratinocytes [29]. In contrast, it was
suggested by Bollag et. al. that AQP3 participated in
keratinocyte early differentiation regulation by regulating lipid
synthesis [39]. Kim and Lee also demonstrated that attenuated
expression of AQP3 led to a decreased expression of keratin
10 in response to calcium induced differentiation [41]. The
disagreement between our findings and other reports could be
due to several possibilities. First, in mouse skin, AQP3
expression is restricted to the proliferating basal layer whereas
in human skin, it is expressed in both basal and differentiating
spinous layers [12,28]. The difference in expression patterns of
AQP3 suggests human AQP3 may have acquired new
functions in differentiating cells. Second, technical differences
may create the discrepancy. In our study, we assessed the
effect of AQP3 silencing in proliferating keratinocytes when it
was highly expressed and found that AQP3 attenuation led to
increased expression of differentiation markers when their
expression were supposed to be low or undetectable. We also
extended the siRNA study to one week time point when
keratinocytes underwent early differentiation, the effect of
AQP3 on differentiation markers persisted (data not shown). In
other AQP3 silencing studies, high concentration calcium was
used to induce differentiation during a lengthy period of time.
Various differentiation inducing agents, such as calcium, PMA
and 1,25-dihydroxyvitamin D3 induce differentiation through
different or partially overlapping mechanisms [42]. It may be
AQP3 in Epidermal Differentiation and Inflammation
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Figure 2.  AQP3 is a transcriptional target of Notch signaling.  (A) HKCs reverse transfected with siRNAs against CSL or
scrambled control were analyzed 1 week later (in differentiating condition) by qRT-PCR and immunoblot of the indicated genes and
proteins. mRNA levels were normalized to reference ribosomal gene RPLP0, and presented as mean fold-change over control ±
S.E.M. n=3. ** p< 0.01, *** p < 0.001, **** p<0.0001, Hes1, Keratin 10 and Involucrin were used as indicators of endogenous Notch
activity, γ-tubulin served as loading control. (B) Differentiating HKCs were treated with DAPT (10μM) or DMSO control for 72 hours
followed by qRT-PCR and immunoblot analysis of the indicated genes and proteins. The analysis was done as in (A). **** p<0.0001,
n=3. (C) Proliferating HKCs were infected with retroviruses expressing activated Notch1 or GFP followed, 72 hours later, by qRT-
PCR and immunoblot analysis of AQP3. Hey1 was used as an indicator of endogenous Notch activity. The analysis was done as in
(A). * p<0.05, *** p<0.001, n=3. (D) Chromatin immuno-precipitation (ChIP) analysis of CSL binding to the regulatory region of the
AQP3 gene. Left panel: schematic representation of the AQP3 gene locus based on ChIP-seq information on different chromatin
states as provided by the ENCODE project. The location of CSL binding site in the AQP3 gene was analyzed using Mat-inspector
software. Right panel: HKCs were processed for ChIP analysis using CSL antibody or non immune IgG. Results are expressed as
mean fold of enrichment ± S.E.M. n=2, for each indicated binding site, after immunoprecipitation with CSL antibody or non immune
IgG, relative to enrichment for the negative control region.
doi: 10.1371/journal.pone.0080179.g002
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possible that the effect of AQP3 on differentiation was
counteracted by calcium. In addition, the effect of AQP3 siRNA
may be lost after prolonged experimental procedure and thus
lead to a misleading conclusion. Moreover, primary
keratinocytes have very low transformation efficiency. In our
study, we used high titer retrovirus to achieve homogenous
expression of the transgene and to eliminate the effect from
uneven transfection. Finally, experimental time points in our
investigation were selected to best reflect and evaluate the
physiological impact. For example, due to its association with
corepressor complexes, there are two possible consequences
of CSL silencing. First, if it occurs in the absence of Notch
activation, Notch targets which are normally repressed by CLS
could be activated. Second, if CSL is silenced in parallel with
Notch receptor activation, Notch signaling will be significantly
impaired. In our study, the effect of CSL silencing on AQP3
was examined at a time point (1 week post transfection) when
Figure 3.  Attenuated AQP3 expression promotes differentiation through activating Notch1.  (A) HKCs reversely transfected
with siRNAs against AQP3 or scrambled control were analyzed 72 week later (in proliferating condition) by qRT-PCR and
immunoblot of AQP3. The analysis was done as in Figure 2A. **** p<0.0001 n=3. (B) Alamar blue cell proliferation assay of HKCs
with AQP3 silencing. HKCs reverse transfected with siRNAs against AQP3 or scrambled control as in (A). 48 hours post-
transfection, cells were trypsinized and plated in 96-well plate at a density of 1000 cells/well in triplicate. Fluorescence intensity was
measure for four consecutive days. Data are presented as mean fold change of fluorescence intensity ± S.E.M. over day 1. *
p<0.0001, n=3. (C) Same samples as in (A) were analyzed by qRT-PCR of the indicated genes. (D) Same samples as in (A) were
analyzed by qRT-PCR and immunoblot of the indicated genes and proteins. * p<0.0001, n=3. (E) HKCs were reverse transfected
with siRNAs against AQP3 or scrambled control, followed by 48 hours later, incubation with DMSO or DAPT (10μM) for additional 3
days. The expression of indicated genes were analyzed by qRT-PCR. Results are presented as mean fold-change over control ±
S.E.M. n=3. One-way ANOVA was used for statistical analysis. ** p= 0.0023, *** p=0.0001.
doi: 10.1371/journal.pone.0080179.g003
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Notch was activated (Figure 1C) and it represented a Notch
signaling deficiency condition.
Notch signaling plays a critical role in epidermal homeostasis
by promoting terminal differentiation to maintain epidermal
barrier integrity, mediating communication between epithelial
and immune cells to prevent inflammation and tumorigenesis
[27,36,43]. The identification of AQP3-Notch1 interconnection
suggests that Notch signaling may play a role in epidermal
water homeostasis and lipid biosynthesis. It has been reported
that deficiency of Fbxw7, a negative regulator of Notch
signaling, leads to massive lipid deposition in the liver, a
phenotype which can be corrected by Notch inhibition [44]. It
would be informative to evaluate whether there is any change
in glycerol level, transepidermal water loss and lipid content
and composition in the epidermis of Notch null mice. The
reciprocal effect of AQP3 on Notch1 was limited to protein
level, suggesting the effect was post-transcriptional.
Interestingly, a recent study by Roti et. al. demonstrated that
calcium channels are required for the maturation of oncogenic
Notch1 in T cell acute lymphoblastic leukemia [45]. It would be
of great interest to see how AQP3 mediated water/glycerol
transport regulates Notch1 protein expression.
Dysregulated expression of AQP3 and Notch receptors have
been reported in a number of skin diseases, including atopic
dermatitis [34–36], psoriasis [46,47] and skin cancer [21,27,48].
Most studies demonstrated an inverse expression pattern of
AQP3 and Notch1, supporting the reciprocal negative feedback
loop identified in our study. We showed that elevated
Figure 4.  Increased AQP3 expression suppresses the expression of differentiation markers and induces the expression of
pro-inflammatory cytokines.  (A) HKCs were infected with retroviruses expressing AQP3 or GFP followed, 72 hours later
(differentiating condition), by qRT-PCR and immunoblot analysis of the indicated genes and proteins. The analysis was done as in
Figure 1. * p< 0.0001, n=3. (B) HKCs were either reverse transfected with siRNAs against AQP3 or scrambled control and analyzed
96h later (differentiating condition) or infected with retroviruses expressing AQP3 or GFP and analyzed 72 hours later (differentiating
condition) by qRT-PCR analysis of the indicated genes. In parallel, differentiating HKCs were treated with DAPT (10μM) or DMSO
control for 72 hours followed by qRT-PCR analysis of the indicated genes. The analysis was done as in Figure 1. ** p< 0.01, *** p <
0.001, **** p<0.0001, n=3.
doi: 10.1371/journal.pone.0080179.g004
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expression of AQP3 led to a reduced expression of
differentiation markers, filaggrin in particular and an increased
expression of CCL5 and TNFα, two of the most prominent
cytokines in atopic dermatitis. Moreover, the changes induced
by AQP3 mirrors the effect of Notch inhibition, suggesting
AQP3 might not play a passive role in the development of
atopic dermatitis.
The altered distribution and expression of aquaporins
(AQP3) in pathological conditions have led to the growing
consensus that modulation of AQPs functions may be
therapeutically useful. A number of factors have been
implicated in AQP3 regulation, including PPARγ [49], TNFα
[50], retinoic acid [51,52], EGFR [53], calcium [42] and low pH
[12]. The identified Notch1/AQP3 interconnection provides a
regulatory mechanism for both factors. In the light that their
inverse expression pattern is present in several skin diseases,
it is worth evaluating whether the Notch1/AQP3 functional axis
is present in those pathological conditions. Further
characterization of this interconnection may be of great
potential therapeutic use.
Materials and Methods
Ethics Statement
The use of discarded human skin tissues for keratinocyte
isolation was specifically approved by the Medical Ethics
Committee of Tongji Medical College, Huazhong University of
Science and Technology (Ethics approval No. 2011S007 and
2012S052). The committee waived the need for written
informed consent from patients.
Keratinocyte preparation and cell culture
Primary human keratinocytes (HKC) were isolated from
discarded skin samples from abdominoplasty procedures with
patients’ and institutional approvals. Briefly, connective tissue
was removed and the skin was incubated overnight in 10mg/ml
dispase at 4°C. The epidermis and dermis were separated and
keratinocytes were collected from 0.025% trypsin digested
epidermis. HKCs were cultured in serum-free keratinocyte-SFM
medium (Gibco) supplemented with 30 μg/ml bovine pituitary
extract (BPE), 0.1 ng/ml rEGF and antibiotics (Gibco) on
collagen coated dishes.
Plasmids and retrovirus
The expression vector for activated Notch1 and
corresponding control vector were kindly provided by Dr. U Just
(Christian-Albrechts-University of Kiel, Germany)[54]. pMSCV-
AQP3 was constructed by cloning the Flag-tagged full-length
cDNA of AQP3 into the XhoI/EcoRI sites of the pMSCV-puro
vector using the following primers: forward 5’-
GATTCCCTCGAGGCCACCATG
GACTACAAGGACGACGATGACAAGGGTCGACAGAAGGAG
CTGGTG-3’ and reverse 5’-GCT
GCTGAATTCCTAGATCTGCTCCTTGTGCTTTCAGATCTGCT
CCTTGTGCTT-3’. Conditions for retrovirus production and
infection were as previously reported [55].
Quantitative real time PCR and Immunodetection
For mRNA analysis, 400 ng of total RNA, isolated with
RNeasy Mini QIAcube kit (Qiagen), was reversely transcribed
using the iScript cDNA synthesis kit (Bio-Rad). Real time PCR
with SYBR Green detection was performed on the Light Cycler
480 instrument, according to manufacturer’s instructions
(Roche). Each sample was prepared in triplicate, and results
were normalized with the expression of the housekeeping 36β4
gene. The list of gene-specific primers for qRT-PCR is provided
in Table 1. For protein analysis, cells were lysed in RIPA buffer
(50 mM Tris-HCl pH 7.4, NP-40 1%, Na-deoxycholate 0.25%,
NaCl 150mM, EDTA 1mM, DTT 1mM, protease cocktail 1x).
Whole cell extract proteins (20 μg) were separated
electrophoretically on 15-well 4–12% NuPAGE Bis-Tris
polyacrylamide gels (Invitrogen). Proteins were transferred to
nitrocellulose membrane (Invitrogen), blocked in 5% nonfat
milk with 0.1% Tween-20 in phosphate-buffered saline.
Membranes were probed with different antibodies, as indicated.
Immunoreactive bands were visualized using SuperSignal
West Pico chemiluminescence substrate (Thermo Scientific)
and exposed to x-ray film. The antibodies used in the studies
are as follows: Notch1 (sc-6014R) and AQP3 (sc-9885) from
Santa Cruz; cleaved Notch1 (2421) from Cell Signaling; Hes1
(AB5702) from chemicon, involucrin (Mob270) and γ-tubulin
(GTU-88) from Sigma, keratin 10 (PRB-159P), keratin 1
(PRB-149p) and loricrin (PRB-145p) from Covance. All the
mRNA and protein studies were performed three times.
Chromatin Immunoprecipitation (ChIP)
HKCs were cross-linked with 1% formaldehyde at RT for 10
min, followed by the addition of glycine to a final concentration
of 125mM to terminate cross-link reaction. After washing with
PBS, cells were scraped off and resuspended in SDS lysis
buffer (Millipore) and sonicated by ultrasonic reactor Branson
Sonifier 450 and DNA was sheared to 100-400bp. The
processed chromatin was used for ChIP assays using the ChIP
assay kit (Millipore) with CSL antibody (5313) from Cell
Signaling. The relative amount of precipitated DNA was
measured by real time PCR analysis using primers against
predicted binding sites for CSL at AQP3, HES1 and HES4
promoters, respectively or a negative region located in α-
satellite region which lack of CSL binding sites, and calculated
after normalization to total input chromatin, according to the
formula: % input = 2 Ct (input) – Ct (immunoprecipitation), Ct means cycle
threshold. Enrichment fold = % input at predicted locus / %
input at negative locus. All the primers used in ChIP-PCR are
included in table 1.
siRNA Transfection
HKCs were reversely transfected with 30 nM of Silencer
Select siRNAs (Invitrogen) for human AQP3 (S1521, S1523),
CSL (S7251, S7253) and control (4390844) using Hiperfect
reagent (Qiagen), according to manufacturer’s instructions.
Fluorescence microscopy
8um cryostat sections of human skin were fixed with 4%
paraformaldehyde in PBS at room temperature for 30 min.
AQP3 in Epidermal Differentiation and Inflammation
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After permeablization with 0.1% NP-40/PBS, slides were
blocked with 5% normal donkey serum/PBS for 1 hour and
incubated with the primary antibodies in the blocking buffer at
4° C overnight. After 3 washes with 0.1% NP-40/PBS, slides
were incubated with Alexa 488 (green)- conjugated secondary
antibodies (Invitrogen) and Hoechst (Molecular Probes) for one
hour. Fluorescence microscopy was carried out with Nikon
TE300 inverted fluorescence microscope. The primary antibody
used was the same as the one in immunodetection section.
Alamar Blue Assay
Alamar Blue assay (Invitrogen) was used to evaluate cell
proliferation. HKCs transfected with AQP3 or control siRNA.
Three days post-transfection, HKCs were plated in triplicate on
the 96-well collagen coated plates at a density of 1000 cells/
well in 100 μl medium. When measuring proliferation rate, 10 μl
of Alarma Blue reagent was added to the medium for 2 hour at
37° C. Fluorescence was monitored at 530-560 nm excitation
wavelength and 590 nm emission wavelength on the VictorTM
X3 Multilabel Plate Reader (Perkin Elmer, Salem, MA, USA).
Statistical analysis
Prism software 6.0 (GraphPad software Inc.) was used to
assess statistical significance of the results, employing
unpaired Student’s t-test or One-way ANOVA. All quantitative
real-time PCR samples were tested in triplicate and error bars
represent S.E.M. P-values less than 0.05 were considered
significant.
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